| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/16/2000 | US6063624 Separating platelet-rich plasma from whole blood, separating platelets from plasma, resuspending said platelet concentrate in a hypertonic solution of sodium chloride or potassium chloride; for storage or transfusion |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063599 Nucleic acid sequence of parasite polypeptide; for diagnosis of parasitic helminth infection; for the development of vaccines to prevent helminth and nematode infection |
| 05/16/2000 | US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| 05/16/2000 | US6063375 Semiallogeneic cell hybrids and related methods for treating cancer |
| 05/16/2000 | US6063373 Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/16/2000 | US6063297 Separation of blood cells from liquid suspension |
| 05/16/2000 | CA2065286C Treatment of chronic inflammatory conditions |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026393A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026347A1 Methods for the production of tcr gamma delta t cells |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000025911A1 Use of an adsorbent gel for eliminating and purifying biomolecules |
| 05/11/2000 | WO2000025839A1 Method for preparing bone material |
| 05/11/2000 | WO2000025827A2 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | WO2000025813A1 CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 05/11/2000 | WO2000025810A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment |
| 05/11/2000 | WO2000025761A1 Capsules with porous mineral cortex |
| 05/11/2000 | WO2000025583A1 Recombinant keratinocytes and use thereof |
| 05/11/2000 | WO2000008130A3 Method for preparing a cartilage cell suspension |
| 05/11/2000 | WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/11/2000 | WO2000007571A3 Formulations having probiotically active microorganisms |
| 05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | CA2349674A1 Capsules with porous mineral cortex |
| 05/11/2000 | CA2349505A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348777A1 Rotavirus subunit vaccine |
| 05/11/2000 | CA2348745A1 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | CA2348736A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 05/11/2000 | CA2344972A1 Cancer immunotherapy and diagnosis using universal tumor associated antigens, including htert |
| 05/10/2000 | EP0999280A2 Episomally replicating vector, its preparation and use |
| 05/10/2000 | EP0998938A2 Antimicrobials, methods of their manufacture and use thereof |
| 05/10/2000 | EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 05/10/2000 | EP0998576A2 Bovine adenovirus type 3 genome |
| 05/10/2000 | EP0998307A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/10/2000 | EP0998298A2 Method of an increasing the antigen presenting ability of monocytes |
| 05/10/2000 | EP0998295A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients |
| 05/10/2000 | EP0818202A4 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid |
| 05/10/2000 | EP0671922B1 Fluidized intestinal submucosa and its use as an injectable tissue graft |
| 05/10/2000 | CN1252840A Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/10/2000 | CN1252729A Production process for intravenous immune serum globulin and resultant product |
| 05/10/2000 | CN1252727A Method and composition for treating sleep apnea |
| 05/10/2000 | CN1252439A Live microbe composite and its preparation |
| 05/10/2000 | CN1252408A Serial animal globulin foods and their production process |
| 05/10/2000 | CN1252307A AIDS vaccine injecta |
| 05/10/2000 | CN1252303A Hyperostereogeny treating medicine and its preparation |
| 05/10/2000 | CN1252299A Antiphlogistic cough-relieving medicine |
| 05/10/2000 | CN1252287A Hepatosis treating medicine and its preparation |
| 05/10/2000 | CN1252286A Medicine for pulmonary diseases and its preparation |
| 05/10/2000 | CN1252283A Honey preparation to treat hand dermatitis caused by silk reeling |
| 05/10/2000 | CN1252282A Royal jelly-bee glue powder capsule and its production process |
| 05/10/2000 | CN1252281A Tinea pedis treating medicine-Fengbao |
| 05/10/2000 | CN1252280A Biological health article with immunity regulating function |
| 05/10/2000 | CN1252279A Soluble heme and its preparation process and hematic composite with it |
| 05/10/2000 | CN1252278A Nutriment containing Zn and Ca and beaver meat |
| 05/10/2000 | CN1052233C Alkaloids from mappia foetida, the use and formulations containing them |
| 05/10/2000 | CN1052163C Composition for curing gallstones and kidney stones |
| 05/10/2000 | CN1052162C Production method of traditional Chinese medicine pills for hyperostosis |
| 05/10/2000 | CN1052161C Medicine for curing bone tuberculosis and osteomyelitis |
| 05/10/2000 | CN1052158C Pure traditional Chinese medicine santhasan for curing headache and its preparing method |
| 05/10/2000 | CN1052157C Soft liver and contracting spleen tablet |
| 05/09/2000 | US6060595 Inhibition of viral replication |
| 05/09/2000 | US6060582 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 05/09/2000 | US6060450 Administering tau-interferon to treat multiple sclerosis, rheumatoid arthritis, diabetes, and lupus |
| 05/09/2000 | US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders |
| 05/09/2000 | US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
| 05/09/2000 | US6060053 Injectable chondrocyte-carrier suspension for treatment of vesicoureteral reflux and incontinence |
| 05/09/2000 | US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells |
| 05/09/2000 | US6060050 Carrier acts as a growth or maintenance medium for microorganisms in the large bowel or other regions of the gastrointestinal tract. |
| 05/09/2000 | US6060049 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 05/09/2000 | US6060048 Method for transplanting cells into the brain and therapeutic uses therefor |
| 05/09/2000 | US6059979 Rotating centrifuging separator |
| 05/09/2000 | CA2062340C Process for the industrial-scale preparation of a highly pure standardized human von willebrand factor concentrate appropriate for therapeutic use |
| 05/04/2000 | WO2000024917A1 Targeted gene modification by parvoviral vectors |
| 05/04/2000 | WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/04/2000 | WO2000024876A2 Spumavirus isolated from humans |
| 05/04/2000 | WO2000024755A1 Ovary-specific genes and proteins |
| 05/04/2000 | WO2000024437A2 Textured and porous silicone rubber |
| 05/04/2000 | WO2000024420A1 Method for the production of an antiviral agent |
| 05/04/2000 | WO2000024408A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 05/04/2000 | WO2000024378A1 Compositions of microspheres for wound healing |
| 05/04/2000 | WO2000024363A1 Biological material for treating periodontal diseases |
| 05/04/2000 | WO2000024261A1 Stromal cell use |
| 05/04/2000 | WO2000012741A3 Inducible expression system |
| 05/04/2000 | WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/04/2000 | WO2000006703A3 Inhibition of graft versus host disease |
| 05/04/2000 | WO2000006204A3 Genetically engineered cells and tissues |
| 05/04/2000 | WO2000004910A3 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 05/04/2000 | WO2000002909A3 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 05/04/2000 | WO1999066036A9 Transplants for myocardial scars |
| 05/04/2000 | WO1999061066A3 Convection-enhanced delivery of aav vectors |
| 05/04/2000 | WO1999047660A9 Retroviral packaging cell line |
| 05/04/2000 | DE19916085A1 Antiviral agent, e.g. for treating HIV infections, comprising autovaccine obtained by heating blood containing viruses and antigens with protein crosslinking agent |
| 05/04/2000 | DE19849984A1 Verfahren zur Präparation von Knochenmaterial Process for the preparation of bone material |
| 05/04/2000 | CA2348840A1 Method for the production of an antiviral agent |
| 05/04/2000 | CA2348778A1 Targeted gene modification by parvoviral vectors |